DIABETIC MACULAR EDEMA (DME)
Clinical trials for DIABETIC MACULAR EDEMA (DME) explained in plain language.
Never miss a new study
Get alerted when new DIABETIC MACULAR EDEMA (DME) trials appear
Sign up with your email to follow new studies for DIABETIC MACULAR EDEMA (DME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drug could reduce shots for Diabetes-Related vision loss
Disease control Recruiting nowThis study tests a new medicine called EYP-1901 against a standard treatment (aflibercept) for people with diabetic macular edema, a condition that causes vision loss in people with diabetes. About 240 participants will receive either the new drug or the standard one, and researc…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 07:06 UTC
-
New eye injection could help millions with diabetes-related vision loss
Disease control Recruiting nowThis study tests a new medicine called BAT5906 against an approved drug (Lucentis) for people with diabetic macular edema, a condition that causes blurry vision in people with diabetes. About 406 adults aged 18-80 will receive eye injections and be monitored for a year. The goal …
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated May 26, 2026 07:03 UTC
-
Gene therapy injection could ease diabetic eye swelling
Disease control Recruiting nowThis early-stage study tests a gene therapy called LX111 for diabetic macular edema, a condition that causes vision loss from swelling in the back of the eye. About 32 adults who have already responded to standard anti-VEGF injections will receive a single shot of LX111 in one ey…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: EARLY_PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New eye drug could mean fewer shots for Diabetes-Related vision loss
Disease control Recruiting nowThis study tests a new medicine called EYP-1901 against a standard treatment (aflibercept) for people with diabetic macular edema, a condition that causes blurry vision due to diabetes. About 240 adults will receive either the new drug or the standard one, and researchers will ch…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Eye scans may predict which diabetes drug works best
Knowledge-focused Recruiting nowThis study looks at 100 adults with diabetic retinopathy to see if eye scans can predict early response to two different drugs (faricimab and biosimilar ranibizumab). Participants receive three injections and undergo imaging and blood tests. The goal is to find biomarkers that he…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: NA • Sponsor: Osijek University Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC